Find out how some UK companies are developing game-changing technologies in vaccine formulation, manufacture and delivery.
The Covid-19 pandemic has brought vaccines to the forefront of discussions about science and technology innovation. An effective vaccine may well be our only hope of a return to something resembling normality.
Across the globe the race is on to develop and produce high volumes of vaccines quickly. The UK government has put together a Taskforce to coordinate Covid-19 vaccine efforts. Two teams are currently leading the charge: The University of Oxford with an adenovirus-based vaccine candidate and Imperial College London with a self-amplifying RNA vaccine candidate. However, we shouldn’t forget that there is also an ecosystem within the UK of innovative, exciting companies who are developing vaccine-enabling technologies that will enable a better response to Covid-19 challenges and beyond.
Join KTN and the Medicines Manufacturing Challenge Community to find out how some of those UK companies are developing game-changing enabling technologies in vaccine formulation, manufacture and delivery.
_____________________________________________
The Knowledge Transfer Network (KTN) helps businesses get the best out of creativity, ideas and the latest discoveries, to strengthen the UK economy and improve people’s lives.
Find out more about KTN:
Follow us on SlideShare to find the slides from all KTN webcasts:
Subscribe to our YouTube channel to keep up to date with our latest videos:
Find us on LinkedIn, Twitter & Facebook: @KTNUK #KTNUK
